Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal

Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal

Source: 
Xconomy
snippet: 

Cancer immunotherapy leader Merck continued to roll up oncology assets with a deal this morning to acquire privately held Tilos Therapeutics.